Clinical Trial Update: Outpatient Lung Impedance-Guided Preventive Therapy in Patients With Chronic Heart Failure (CHF) [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 outpatient trial evaluating lung impedance-guided preventive therapy in patients with chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Chronic Congestive Heart Failure | Phase 3 | Status: UNKNOWN